NCT/Study#
NCT06248515 /
CO-US-979-6770
A Phase II Parallel Arm Study of Sacituzumab Govitecan-hziy in Patients with Advanced Thymoma and Thymic Carcinoma
DISEASE GROUP:
Thoracic (Lung)
current phase:
Phase II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
